Pharsight

Drugs that contain Drospirenone; Ethinyl Estradiol; Levomefolate Calcium

1. List of Beyaz drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US6441168 BAYER HLTHCARE Stable crystalline salts of 5-methyltetrahydrofolic acid
Jul, 2022

(6 months ago)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7163931 BAYER HLTHCARE Compositions of estrogen-cyclodextrin complexes
Mar, 2022

(11 months ago)

US8617597 BAYER HLTHCARE Pharmaceutical composition containing a tetrahydrofolic acid
Feb, 2030

(7 years from now)

Market Authorisation Date: 24 September, 2010

Treatment: Prevention of pregnancy

Dosage: TABLET;ORAL

How can I launch a generic of BEYAZ before it's patent expiration?
More Information on Dosage

BEYAZ family patents

8

United States

3

Korea, Republic of

3

Australia

3

European Union

2

Spain

2

Israel

2

Japan

2

Slovenia

2

Hungary

2

Croatia

2

China

2

ME

2

EA

2

Czech Republic

2

Canada

2

Denmark

1

Estonia

1

Austria

1

Hong Kong

1

RS

1

Brazil

1

Poland

1

Lithuania

1

Ukraine

1

Slovakia

1

Uruguay

1

Yugoslavia

1

Germany

1

Cyprus

1

Mexico

1

IB

1

South Africa

1

Argentina

1

Portugal

1

Peru

1

Bulgaria

1

Norway

1

New Zealand

1

Taiwan, Province of China

2. List of Safyral drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7163931 BAYER HLTHCARE Compositions of estrogen-cyclodextrin complexes
Mar, 2022

(11 months ago)

US8617597 BAYER HLTHCARE Pharmaceutical composition containing a tetrahydrofolic acid
Feb, 2030

(7 years from now)

Market Authorisation Date: 16 December, 2010

Treatment: Prevention of pregnancy

Dosage: TABLET;ORAL

How can I launch a generic of SAFYRAL before it's patent expiration?
More Information on Dosage

SAFYRAL family patents

8

United States

3

Korea, Republic of

3

Australia

3

European Union

2

Spain

2

Israel

2

Japan

2

Slovenia

2

Hungary

2

Croatia

2

China

2

ME

2

EA

2

Czech Republic

2

Canada

2

Denmark

1

Estonia

1

Austria

1

Hong Kong

1

RS

1

Brazil

1

Poland

1

Lithuania

1

Ukraine

1

Slovakia

1

Uruguay

1

Yugoslavia

1

Germany

1

Cyprus

1

Mexico

1

IB

1

South Africa

1

Argentina

1

Portugal

1

Peru

1

Bulgaria

1

Norway

1

New Zealand

1

Taiwan, Province of China

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic